topic0
Survival [acty] 0.0152035337777
Risk Factors [qnco] 0.0119728580118
HEPATITIS C VIRUS [virs] 0.0105644098654
resection [topp] 0.00872358338756
Study [mnob] 0.00715435657018
Related [qlco] 0.0065650047852
LIVER [bpoc] 0.0060800103965
Methods [inpr] 0.00567010777767
Hepatic [blor] 0.00502440426655
YEARS [tmco] 0.00501431668335
YEAR [tmco] 0.00484873249622
Levels [qlco] 0.00477255819047
Independent [idcn] 0.00475947982387
Group [idcn] 0.00475414643713
Postoperative [tmco] 0.00469245653711
Hepatectomy [topp] 0.00463044906129
Increased [qnco] 0.00460165887838
Hazard Ratio [qnco] 0.00459700599893
treatment [ftcn] 0.00450474654073
Cases [ftcn] 0.00421506855884
CI [geoa] 0.00417027940297
Tumour NOS [neop] 0.00415545719975
Invasion [fndg] 0.00406929183795
control [qlco] 0.00400078268243
Compared [acty] 0.00367799383411
HEPATITIS B VIRUS [virs] 0.00354067785702
CIRRHOSIS [dsyn] 0.00343071515771
included [ftcn] 0.00337250472579
Median [spco] 0.00317892211456
Criteria [inpr] 0.003148897083
Infected [fndg] 0.00313472333189
Identified [qlco] 0.0031328461023
Based [ftcn] 0.00301084986241
Association [menp] 0.00289967634568
CANCER [neop] 0.00284070951537
Preoperative [tmco] 0.00282600411679
Microvascular [ftcn] 0.00278703433298
Subject [grup] 0.00278419322812
Prognostic [inpr] 0.00272789609712
LOWER [spco] 0.00271051848149
topic1
CIRRHOSIS [dsyn] 0.0106540841147
Survival [acty] 0.00886427064791
LIVER [bpoc] 0.00882407069693
YEARS [tmco] 0.00863327965872
Study [mnob] 0.00845193774293
Risk Factors [qnco] 0.0079360711203
Methods [inpr] 0.00740581972827
treatment [ftcn] 0.00715427727343
Cases [ftcn] 0.00657400139355
Group [idcn] 0.00645714475041
HCC [neop] 0.00589287794639
Compared [acty] 0.00575312700829
Groups [idcn] 0.00507267225199
YEAR [tmco] 0.00463594136269
DIAGNOSIS [fndg] 0.00431158148562
HEPATITIS C VIRUS [virs] 0.00427085363495
Human [humn] 0.00418309253692
Hepatectomy [topp] 0.00417319109596
Tumour NOS [neop] 0.00412937251788
Including [ftcn] 0.00370307728186
Identified [qlco] 0.00364246715275
resection [topp] 0.00358190190073
Conclusions [idcn] 0.00354301366293
Performed [ftcn] 0.00350822317989
Postoperative [tmco] 0.00347557558602
Related [qlco] 0.0034236667486
Radiofrequency Ablation [topp] 0.00335882981967
Mortality [qnco] 0.00327315001981
Prognostic Factor [clna] 0.00316637013933
liver resection [topp] 0.00314375145768
Nonalcoholic Steatohepatitis [dsyn] 0.00308021855703
surveillance [ftcn] 0.00306472780482
Hazard Ratio [qnco] 0.00292083569347
HEPATITIS B VIRUS [virs] 0.00289567908966
Independent [idcn] 0.00277772077563
LOWER [spco] 0.00269993242983
Based [ftcn] 0.00268492820903
Transarterial Chemoembolization [topp] 0.00266664201978
SUSTAINED VIROLOGIC RESPONSE [fndg] 0.00264483490868
Increased [qnco] 0.00262628735452
topic2
Study [mnob] 0.00948055668854
Survival [acty] 0.00912488913465
Methods [inpr] 0.00616074731247
treatment [ftcn] 0.00602720249945
DIAGNOSIS [fndg] 0.00555646098083
HEPATITIS B VIRUS [virs] 0.00549819826014
Risk Factors [qnco] 0.00543284724318
Group [idcn] 0.00531431517416
resection [topp] 0.00515791558032
RATIO [qnco] 0.00501872891973
Cases [ftcn] 0.00480187016246
Related [qlco] 0.00477082281355
Tumour NOS [neop] 0.00475875219845
Independent [idcn] 0.00459783496263
YEARS [tmco] 0.00450335640823
Identified [qlco] 0.00441538946669
Conclusions [idcn] 0.00413051335684
Performed [ftcn] 0.00413009122203
DIABETES MELLITUS [dsyn] 0.003995930897
Compared [acty] 0.00387111197887
Based [ftcn] 0.00386133648006
Mortality [qnco] 0.00379896919805
YEAR [tmco] 0.0036970887645
Hepatic [blor] 0.00362866619435
control [qlco] 0.00354437631002
CIRRHOSIS [dsyn] 0.00350903371408
Treated [ftcn] 0.00343390299822
Increased [qnco] 0.00334836150079
Liver Transplantation [topp] 0.00308727782093
NEW [qlco] 0.00289034511253
LIVER [bpoc] 0.00286153823048
Prognostic Factor [clna] 0.00285855020691
Enhanced [acty] 0.00269696397392
FIBROSIS [patf] 0.00265832620468
CI [geoa] 0.00264807645678
HEPATITIS C VIRUS [virs] 0.00264632955678
Preoperative [tmco] 0.00260036736646
therapy [ftcn] 0.0025834827301
Transarterial Chemoembolization [topp] 0.002567813953
CANCER [neop] 0.00252094156103
topic3
Risk Factors [qnco] 0.00796508634231
Study [mnob] 0.00765793541313
Cases [ftcn] 0.00631036362474
Cholangiocarcinoma [neop] 0.00613894729499
LIVER [bpoc] 0.00552975122893
Methods [inpr] 0.00552329876301
Tumour NOS [neop] 0.00544464903462
HCV [virs] 0.00484463211267
Criteria [inpr] 0.00459862131372
Radiofrequency Ablation [topp] 0.00458896983861
Liver Cancer [neop] 0.00446339853957
resection [topp] 0.00445810650916
lesions [fndg] 0.00442295662542
CIRRHOSIS [dsyn] 0.00435036461797
CANCER [neop] 0.0042580377742
Conclusions [idcn] 0.00400870707732
Compared [acty] 0.00396932622465
CI [geoa] 0.00393832231517
treatment [ftcn] 0.00378217344126
YEAR [tmco] 0.00371130920872
Hepatic [blor] 0.00355325754809
Mortality [qnco] 0.0034253976593
HCC [neop] 0.00337445116439
Related [qlco] 0.00326830639973
Nonalcoholic Fatty Liver Disease [dsyn] 0.00309384661854
LOCAL [spco] 0.00302216190138
Increased [qnco] 0.00300569094617
Based [ftcn] 0.00296109550704
Nonalcoholic Steatohepatitis [dsyn] 0.00294807421432
YEARS [tmco] 0.00290737390356
Important [qlco] 0.00286360411588
Performed [ftcn] 0.00281388613414
LIVER DISEASE [dsyn] 0.0027804737813
Imaging [diap] 0.00277607072692
Higher [qlco] 0.00277052862959
Tumors [neop] 0.00275778286798
Pathology [bmod] 0.00273913911741
Odds Ratio [qnco] 0.00263352398343
LOWER [spco] 0.00260198219862
DIAGNOSIS [fndg] 0.00256970000692
topic4
Study [mnob] 0.0113749909213
Risk Factors [qnco] 0.0112246832305
Liver Transplantation [topp] 0.00964305699573
Survival [acty] 0.00960669785003
Related [qlco] 0.00908183975424
LIVER [bpoc] 0.00903272105313
CIRRHOSIS [dsyn] 0.00822163116849
YEARS [tmco] 0.00777339056159
Methods [inpr] 0.00694764118306
HEPATITIS B VIRUS [virs] 0.00668126691141
Compared [acty] 0.00547371612438
Conclusions [idcn] 0.00544137630745
resection [topp] 0.00518965471962
Tumour NOS [neop] 0.00487330499473
Mortality [qnco] 0.00478302868095
Group [idcn] 0.00462833890814
Cholangiocarcinoma [neop] 0.0045887565871
HEPATITIS C VIRUS [virs] 0.00458313299935
Cases [ftcn] 0.00453984584542
Levels [qlco] 0.00408796602771
YEAR [tmco] 0.0040830389041
CANCER [neop] 0.00407786041317
Intrahepatic Cholangiocarcinoma [neop] 0.00405037896823
HCV [virs] 0.0037242776615
Independent [idcn] 0.00370254860101
Higher [qlco] 0.00367395375373
Invasion [fndg] 0.00350098838505
Performed [ftcn] 0.00314866238944
treatment [ftcn] 0.00293905548962
Hepatectomy [topp] 0.00288906379567
Median [spco] 0.00267081215928
Association [menp] 0.00264708695266
CI [geoa] 0.00263650121231
Groups [idcn] 0.00259952405499
HIV [virs] 0.00259052462097
FIBROSIS [patf] 0.00258697109807
Hepatic [blor] 0.00254153835245
Present [qnco] 0.00250274976919
control [qlco] 0.00249917647563
Subject [grup] 0.0023632037832
topic5
CIRRHOSIS [dsyn] 0.0100891571278
Group [idcn] 0.00988053255451
Study [mnob] 0.00957825531358
treatment [ftcn] 0.00889904097896
Invasion [fndg] 0.00848953985232
resection [topp] 0.00735571941201
Risk Factors [qnco] 0.00704027595255
Survival [acty] 0.00663653012487
Radiofrequency Ablation [topp] 0.00536561332532
LIVER [bpoc] 0.00501852484767
Methods [inpr] 0.00497361721103
HEPATITIS B VIRUS [virs] 0.00495830859814
Tumour NOS [neop] 0.00495440274287
Liver Transplantation [topp] 0.00491829842498
Performed [ftcn] 0.00483128826448
Compared [acty] 0.00477420045997
Independent [idcn] 0.00450418660166
included [ftcn] 0.00418580024689
Hepatic [blor] 0.00415987223958
YEAR [tmco] 0.00405688766661
FIBROSIS [patf] 0.0040404843486
Hepatectomy [topp] 0.00396051005985
Evaluated [hlca] 0.00367404232015
Preoperative [tmco] 0.0034265780105
Treated [ftcn] 0.00328301136248
Related [qlco] 0.00321762277327
Progression [patf] 0.00319855010562
YEARS [tmco] 0.00317302077093
Microvascular [ftcn] 0.00314125361126
Conclusions [idcn] 0.00309315505656
Cases [ftcn] 0.00307106206791
Hazard Ratio [qnco] 0.00306632922994
Complications [patf] 0.00302527427061
Groups [idcn] 0.00300393459366
Median [spco] 0.00296610245564
Increased [qnco] 0.0029167632938
Identified [qlco] 0.00283047298647
Tumors [neop] 0.00277824809042
Pathology [bmod] 0.00266698301365
SERUM [bdsu] 0.0026178919494
topic6
Risk Factors [qnco] 0.0107623156298
YEARS [tmco] 0.00697525246222
Tumour NOS [neop] 0.00678144641653
Increased [qnco] 0.00630063755679
Study [mnob] 0.00621465308453
LIVER [bpoc] 0.00619700980536
Methods [inpr] 0.00606105630863
HEPATITIS B VIRUS [virs] 0.00586999752435
Radiofrequency Ablation [topp] 0.0053356758471
treatment [ftcn] 0.00497838713828
ABLATION [topp] 0.00457063783594
Cases [ftcn] 0.00455956447141
Compared [acty] 0.00425425910621
Related [qlco] 0.00406515599257
Metastasis [neop] 0.00375620618758
Treated [ftcn] 0.00364915375783
Survival [acty] 0.00338713911477
Pathology [bmod] 0.0033352218369
Association [menp] 0.00328709472881
Intrahepatic [spco] 0.00323709252619
Independent [idcn] 0.00319370462506
YEAR [tmco] 0.00314097536675
Conclusions [idcn] 0.00313081254904
Group [idcn] 0.00311858072563
CIRRHOSIS [dsyn] 0.00307055167649
CCA [cgab] 0.00300884293104
Liver Cancer [neop] 0.00299773993688
resection [topp] 0.00297596141084
LOCAL [spco] 0.00297351694484
Tumors [neop] 0.00296548094303
Important [qlco] 0.00287841226835
Levels [qlco] 0.00280807666172
Induced [ftcn] 0.00276104523846
SERUM [bdsu] 0.00270716945618
CANCER [neop] 0.00261706859357
SMALL [qnco] 0.00255803563896
Mortality [qnco] 0.00255019971772
Performed [ftcn] 0.00252758321024
Hepatic [blor] 0.00252046297449
Mice [mamm] 0.00251639807522
topic7
treatment [ftcn] 0.0119518119836
Study [mnob] 0.0112156646013
Risk Factors [qnco] 0.0107864066808
YEARS [tmco] 0.00782141766561
Survival [acty] 0.00616022177317
Group [idcn] 0.00600646331874
Related [qlco] 0.00559986730337
CIRRHOSIS [dsyn] 0.00513021861783
Hepatectomy [topp] 0.0050080641941
LIVER [bpoc] 0.00466930483871
Methods [inpr] 0.0045310579394
HCV [virs] 0.00441142245612
Independent [idcn] 0.00439629843566
Higher [qlco] 0.00419714037596
TIME [tmco] 0.00403292826377
Increased [qnco] 0.00399386386246
Levels [qlco] 0.00397839813978
Cases [ftcn] 0.00382031975001
Identified [qlco] 0.00374419646089
HCC [neop] 0.0036937077222
Tumour NOS [neop] 0.00362196669587
YEAR [tmco] 0.00345563869616
Reserve [acty] 0.00336681098152
SUSTAINED VIROLOGIC RESPONSE [fndg] 0.00336160448172
Conclusions [idcn] 0.00317988463853
resection [topp] 0.0031748803067
Portal Vein Thrombosis [dsyn] 0.00314871661776
CANCER [neop] 0.00312153214634
Liver Transplantation [topp] 0.00304282293192
Groups [idcn] 0.0030150044138
rights [qlco] 0.00300504071091
Methylation [moft] 0.00296506075604
Treated [ftcn] 0.00294394099915
Odds Ratio [qnco] 0.00292406673571
Low [qlco] 0.00291013092014
Compared [acty] 0.00287572854512
Median [spco] 0.0028241684993
Performed [ftcn] 0.00278306938198
Important [qlco] 0.00272281138624
HEPATITIS C VIRUS [virs] 0.00266044600043
topic8
Radiofrequency Ablation [topp] 0.0151057171372
LIVER [bpoc] 0.00998230180249
Cases [ftcn] 0.00777300463036
Related [qlco] 0.00721814532464
resection [topp] 0.00664577175307
Study [mnob] 0.00544648715259
Risk Factors [qnco] 0.00520893556666
Tumour NOS [neop] 0.00507102001694
Survival [acty] 0.00495082020502
DIAGNOSIS [fndg] 0.00461571477315
Hepatic [blor] 0.00451805766251
Methods [inpr] 0.00446036697366
Group [idcn] 0.00444492622456
Compared [acty] 0.0040784129243
treatment [ftcn] 0.00391241061406
Nonalcoholic Fatty Liver Disease [dsyn] 0.00374959865949
Enhanced [acty] 0.00370083597975
Contrast [irda] 0.00367557567662
Complications [patf] 0.00353382820871
Including [ftcn] 0.00348617141416
YEAR [tmco] 0.00346528441965
Pathology [bmod] 0.00343932504649
Tumors [neop] 0.00343460612317
Observed [ftcn] 0.00338654769937
CIRRHOSIS [dsyn] 0.00315466742587
HEPATITIS B VIRUS [virs] 0.00307175245952
Conclusions [idcn] 0.00304378920702
Transplantation [topp] 0.00301729724835
HCV [virs] 0.00293994777631
control [qlco] 0.0028689220837
Independent [idcn] 0.00286803647915
Groups [idcn] 0.00282691259967
LOCAL [spco] 0.00278840444396
Imaging [diap] 0.00275920483011
YEARS [tmco] 0.00275791012271
Mortality [qnco] 0.00272876997264
Suggest [idcn] 0.00264548856239
Criteria [inpr] 0.00262852685101
Performed [ftcn] 0.00260171332173
lesions [fndg] 0.00257606242595
topic9
Risk Factors [qnco] 0.00834385948741
Nonalcoholic Fatty Liver Disease [dsyn] 0.00790319543833
Study [mnob] 0.00761820669534
LIVER [bpoc] 0.00710610945104
Cases [ftcn] 0.00704081666229
Tumour NOS [neop] 0.00613126507678
Intrahepatic Cholangiocarcinoma [neop] 0.00488329656551
Increased [qnco] 0.00461870757771
Hepatic [blor] 0.00459224341063
Identified [qlco] 0.00441663820007
Association [menp] 0.0043081824538
Cholangiocarcinoma [neop] 0.0043076325803
YEARS [tmco] 0.00420344798174
Related [qlco] 0.00411234856045
CANCER [neop] 0.00389007009323
Methods [inpr] 0.00382377694426
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00379036685347
Pathology [bmod] 0.00363082750015
DIAGNOSIS [fndg] 0.00347863039374
treatment [ftcn] 0.00333317495234
Present [qnco] 0.00331007833774
YEAR [tmco] 0.00326748610172
Independent [idcn] 0.00317987792439
control [qlco] 0.00308978023493
Survival [acty] 0.00308076195894
Including [ftcn] 0.00292212065031
resection [topp] 0.00280914454495
Mortality [qnco] 0.00278374268506
Performed [ftcn] 0.00274085665201
HEPATITIS C VIRUS [virs] 0.00270821938561
Odds Ratio [qnco] 0.00264314467644
Observed [ftcn] 0.00251041156992
Group [idcn] 0.0025044591097
Conclusions [idcn] 0.00245566058944
Based [ftcn] 0.00244149855633
LIVER CIRRHOSIS [dsyn] 0.00234116812467
Evaluate [hlca] 0.00232900570679
rights [qlco] 0.00232073691169
Important [qlco] 0.0022910641494
Suggest [idcn] 0.00223532337226
